COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development.

ABSTRACT: The world is presently in crisis facing an outbreak of a health-threatening microorganism known as COVID-19, responsible for causing uncommon viral pneumonia in humans. The virus was first reported in Wuhan, China, in early December 2019, and it quickly became a global concern due to the pandemic. Challenges in this regard have been compounded by the emergence of several variants such as B.1.1.7, B.1.351, P1, and B.1.617, which show an increase in transmission power and resistance to therapies and vaccines. Ongoing researches are focused on developing and manufacturing standard treatment strategies and effective vaccines to control the pandemic. Despite developing several vaccines such as Pfizer/BioNTech and Moderna approved by the U.S. Food and Drug Administration (FDA) and other vaccines

SUBMITTER: Bostanghadiri N 

PROVIDER: S-EPMC10480030 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature